News About: Goverment
Multinational firm to be under siege in antitrust debate
Multinational drug manufacturers will face the health ministry’s scrutiny for their monopolistic behaviors with Zuellig Pharma Korea (ZPK).
The Ministry of Health, Welfare and Family Affairs said it had consecutive...
Government, medical doctors on alert to fight influenza A
In Korea, over 4,000 people are diagnosed daily as having contracted the H1N1 type flu with hospitals reporting roughly 30 percent of all people who come in to be treated for common cold infected with the virus.
I...
Consensus on Health Insurance fee needed
Around this time of the year, clamor rises over the increase in National Health Insurance fees.
The government says the rise is inevitable for better coverage, but people seem to be disgruntled over the increasing ...
Biosimilars unlikely to be commercialized within 2 or 3 years
The government will need to proceed with biosimilar projects with more caution as the availability of second generation biologic products that offer superior dosing and/or therapeutic efficacy to the original referenc...
Pharmacists withdraw suit over doctors’ dispensing in state-run hospitals
Seoul Pharmaceutical Association has recently decided to withhold its proposed suit against doctors’ dispensing of flu-related medicines in government-designated hospitals until next March, as the number of confirmed ...
Discontent brewing over deferred direct dealing with wholesalers
A complaint surrounding the delayed implementation of the direct dealing with local pharmaceutical wholesalers on the part of Zuellig Pharma Korea’s outsourcing partners as members of the Korean Research based Pharmac...
Death toll from new influenza A reach 20
This country's death toll from the disease increased to 20, with two additional fatalities confirmed on October 20.
A two-year-old girl and a 66-year-old man have recently died after being infected with the type-A ...
Sleeping pills use by Korean youths soars
The use of sleeping pills among children and very young adults rose 53.3 percent from 2006 to 2008, in yet another sign that parents and doctors are increasingly turning to prescription medications to solve childhood ...
Deregulation to spur commissioned drug markers
Rigid regulations are making it difficult for commissioned pharmaceutical manufacturers to sell any drugs without omission of clinical trials.
The government said on October 16 that rules governing the commissioned...
Tamiflu’s side effect cases top 169 for 9 years
A total of 169 cases of side-effects caused by Tamiflu (oseltamivir phosphate) to the Korea Food and Drug Administration have been reported for the last nine years (2000 to October 14, 2009).
Tamiflu is a medicati...
